Global Pharmaceuticals & Biotech Most Popular Stocks

GenFleet Therapeutics (Shanghai)

Market Cap: HK$13.2b

Operates as a biopharmaceutical company that focuses on developing novel treatment options in the fields of oncology that cover different lines of treatments of multiple solid tumors, as well as autoimmune and inflammatory diseases.

Aurinia Pharmaceuticals

Market Cap: US$1.7b

A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.

Celltrion Pharm

Market Cap: ₩2.4t

A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.

Shanghai Yizhong Pharmaceutical

Market Cap: CN¥12.0b

Shanghai Yizhong Pharmaceutical Co., Ltd.

Celldex Therapeutics

Market Cap: US$1.7b

A biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.

Luye Pharma Group

Market Cap: HK$13.0b

Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.

Zhejiang Hisun Pharmaceutical

Market Cap: CN¥11.9b

Engages in the research, development, production, and sale of biological and generic drugs in China.

Bio-Thera Solutions

Market Cap: CN¥11.9b

A biopharmaceutical company, researches and develops novel therapeutics for the treatment of cancer, autoimmune, cardiovascular, eye diseases, and other severe unmet medical needs in China and internationally.

NATCO Pharma

Market Cap: ₹147.0b

A pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.

MannKind

Market Cap: US$1.6b

A biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States.

Lepu Biopharma

Market Cap: HK$12.6b

A biopharmaceutical company, focuses on the discovery, development, and commercialization of first-in class and best-in-class drug candidates in anti-tumor targeted therapy and oncology immunotherapy in China and internationally.

Chongqing Genrix Biopharmaceutical

Market Cap: CN¥11.6b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.

Twist Bioscience

Market Cap: US$1.6b

Manufactures and sells synthetic DNA-based products.

Nanjing Leads Biolabs

Market Cap: HK$12.5b

A clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide.

BioCryst Pharmaceuticals

Market Cap: US$1.6b

A biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.

Neuren Pharmaceuticals

Market Cap: AU$2.4b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

Mayinglong Pharmaceutical Group

Market Cap: CN¥11.4b

Engages in the manufacturing and sale of Chinese and Western medicines primarily in China.

Xiamen Kingdomway Group

Market Cap: CN¥11.4b

Engages in the manufacturing and sale of the nutrition and health products in China and internationally.

Square Pharmaceuticals

Market Cap: ৳193.6b

Manufactures, markets, and sells pharmaceutical products in Bangladesh and internationally.

Sawai Group Holdings

Market Cap: JP¥237.7b

Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals.

Lumosa Therapeutics

Market Cap: NT$48.2b

A clinical-stage pharmaceutical company, develops therapies and solutions for neurological and oncological diseases in Taiwan, Asia, the Americas, and Europe.

Changzhou Qianhong BiopharmaLTD

Market Cap: CN¥11.2b

Manufactures and distributes polysaccharide and protease drugs in China.

Anbio Biotechnology

Market Cap: US$1.6b

Provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.

Edgewise Therapeutics

Market Cap: US$1.6b

A biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.

Liaoning Chengda BiotechnologyLtd

Market Cap: CN¥11.1b

A biotechnology company, engages in the research and development, production, and sales of vaccines for human use in China.

Viridian Therapeutics

Market Cap: US$1.6b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

Indegene

Market Cap: ₹138.1b

Operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally.

Harmony Biosciences Holdings

Market Cap: US$1.6b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

Phibro Animal Health

Market Cap: US$1.5b

Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.

Tianjin Chase Sun PharmaceuticalLtd

Market Cap: CN¥11.0b

Engages in the research and development, production, and sale of various pharmaceutical products in China and internationally.

China Traditional Chinese Medicine Holdings

Market Cap: HK$12.0b

China Traditional Chinese Medicine Holdings Co.

D&D Pharmatech

Market Cap: ₩2.2t

A clinical-stage biotech company, develops medicines in South Korea and the United States.

Alphamab Oncology

Market Cap: HK$11.9b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biotherapeutics for cancer treatment in the People’s Republic of China.

Faes Farma

Market Cap: €1.3b

Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide.

Vcanbio Cell & Gene Engineering

Market Cap: CN¥10.9b

Engages in the preparation and storage of cell detection tests in the People’s Republic of China.

SKAN Group

Market Cap: CHF 1.2b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.